David de Lucena, MD
- 2Articles
- 7.3KReads
- 2009–2010Active
- 15Collaborators
- 232Citations
About
David de Lucena, MD, has published research focused on schizophrenia and schizoaffective disorders. His work includes clinical trials investigating the use of memantine as an adjunctive therapy to clozapine in treatment-refractory schizophrenia. His studies, published between 2009 and 2010, examine both negative and positive symptom improvement as well as serum brain-derived neurotrophic factor levels in this context.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
